One Small Step for FDA...

The coming wave of nanotechnology-enhanced drug formulations and delivery vehicles should not present an immediate challenge to the Food & Drug Administration’s drug approval process, standard drug development procedures or the agency’s legal authority.

But with the advent of any new major technology, there’s always a question as to whether FDA has the resources to stay current with a fast-moving area of science. And...